Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A J Pakarinen

Showing results (11-20 of 34) with videos related to

Pageof 4
Sort By:
Epilepsia|January 1, 1989
Effects of carbamazepine on pituitary responsiveness to luteinizing hormone-releasing hormone, thyrotropin-releasing hormone, and metoclopramide in epileptic patientsJ I Isojärvi, V V Myllylä, A J Pakarinen
Journal of Applied Physiology|September 1, 1976
Plasma renin activity, angiotensin II, and aldosterone during intense heat stressK J Kosunen, A J Pakarinen, K Kuoppasalmi, et al.
Archives of Neurology|June 1, 1990
Serum hormones in male epileptic patients receiving anticonvulsant medicationJ I Isojärvi, A J Pakarinen, P J Ylipalosaari, et al.
Epilepsia|November 1, 1994
Liver enzyme induction and serum lipid levels after replacement of carbamazepine with oxcarbazepineJ I Isojärvi, A J Pakarinen, A Rautio, et al.
Seizure|January 11, 2000
Long-term valproate treatment induces changes in ovarian morphology and serum sex steroid hormone levels in female Wistar ratsE Taubøll, J I Isojärvi, H F Harbo, et al.
European Journal of Clinical Pharmacology|January 1, 1995
Serum sex hormone levels after replacing carbamazepine with oxcarbazepineJ I Isojärvi, A J Pakarinen, A Rautio, et al.
Epilepsia|April 1, 1995
Carbamazepine, phenytoin, sex hormones, and sexual function in men with epilepsyJ I Isojärvi, M Repo, A J Pakarinen, et al.
Epilepsia|June 26, 2001
The regulation of serum sodium after replacing carbamazepine with oxcarbazepineJ I Isojärvi, U E Huuskonen, A J Pakarinen, et al.
Epilepsia|July 1, 1995
Menstrual disorders in women with epilepsy receiving carbamazepineJ I Isojärvi, T J Laatikainen, A J Pakarinen, et al.
The New England Journal of Medicine|November 4, 1993
Polycystic ovaries and hyperandrogenism in women taking valproate for epilepsyJ I Isojärvi, T J Laatikainen, A J Pakarinen, et al.
Pageof 4

Showing results (11-20 of 34) with videos related to

Sort By:
Pageof 4
Epilepsia|January 1, 1989
Effects of carbamazepine on pituitary responsiveness to luteinizing hormone-releasing hormone, thyrotropin-releasing hormone, and metoclopramide in epileptic patientsJ I Isojärvi, V V Myllylä, A J Pakarinen
Journal of Applied Physiology|September 1, 1976
Plasma renin activity, angiotensin II, and aldosterone during intense heat stressK J Kosunen, A J Pakarinen, K Kuoppasalmi, et al.
Archives of Neurology|June 1, 1990
Serum hormones in male epileptic patients receiving anticonvulsant medicationJ I Isojärvi, A J Pakarinen, P J Ylipalosaari, et al.
Epilepsia|November 1, 1994
Liver enzyme induction and serum lipid levels after replacement of carbamazepine with oxcarbazepineJ I Isojärvi, A J Pakarinen, A Rautio, et al.
Seizure|January 11, 2000
Long-term valproate treatment induces changes in ovarian morphology and serum sex steroid hormone levels in female Wistar ratsE Taubøll, J I Isojärvi, H F Harbo, et al.
European Journal of Clinical Pharmacology|January 1, 1995
Serum sex hormone levels after replacing carbamazepine with oxcarbazepineJ I Isojärvi, A J Pakarinen, A Rautio, et al.
Epilepsia|April 1, 1995
Carbamazepine, phenytoin, sex hormones, and sexual function in men with epilepsyJ I Isojärvi, M Repo, A J Pakarinen, et al.
Epilepsia|June 26, 2001
The regulation of serum sodium after replacing carbamazepine with oxcarbazepineJ I Isojärvi, U E Huuskonen, A J Pakarinen, et al.
Epilepsia|July 1, 1995
Menstrual disorders in women with epilepsy receiving carbamazepineJ I Isojärvi, T J Laatikainen, A J Pakarinen, et al.
The New England Journal of Medicine|November 4, 1993
Polycystic ovaries and hyperandrogenism in women taking valproate for epilepsyJ I Isojärvi, T J Laatikainen, A J Pakarinen, et al.
Pageof 4